SynAct Pharma AB (SYNACT.ST)
SEK 9.69
(0.36%)
SEK 9.69
(0.36%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -100.17 Million | -117.55 Million | -64.99 Million | -33.23 Million | -16.12 Million | -24.21 Million |
| Net Income | -215.81 Million | -105.7 Million | -76.69 Million | -31.28 Million | -24.8 Million | -28.39 Million |
| Depreciation & Amortization | 75.33 Million | 1.01 Million | 88 Thousand | - | 338.51 Thousand | 303.56 Thousand |
| Deferred income taxes | -83.21 Million | - | - | - | - | - |
| Stock-based compensation | 7.88 Million | - | - | - | - | - |
| Change in working capital | 30.37 Million | -20.34 Million | 7.09 Million | -2.76 Million | 7.77 Million | -684.83 Thousand |
| Other non-cash items | 85.26 Million | 7.48 Million | 4.51 Million | 815 Thousand | 562.08 Thousand | 4.55 Million |
| Investing Cash Flow | 370 Thousand | 27 Thousand | -6000.00 | -93 Thousand | -498.99 Thousand | - |
| Investments in PPE | - | - | - | - | -498.99 Thousand | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | -6000.00 | -93 Thousand | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 370 Thousand | 27 Thousand | -6000.00 | -93.00 | - | - |
| Financing Cash Flow | 53.98 Million | 200.71 Million | 74.32 Million | 44.72 Million | 12.99 Million | 20.75 Million |
| Debt repayment | -729.00 | -981.00 | -77.00 | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 59.45 Million | 228.94 Million | 80 Million | 49.75 Million | 12.99 Million | 20.75 Million |
| Other Financing Activities | -5.47 Million | -28.23 Million | -5.67 Million | -5.03 Million | 13 Thousand | 20.75 Million |
| Accounts receivables | 19.87 Million | -19.31 Million | -1.21 Million | -530.00 | 1.21 Million | -2.02 Million |
| Accounts payables | 5.1 Million | 182 Thousand | 1.43 Million | - | - | 1.4 Million |
| Inventory | 1000.00 | - | -1000.00 | - | - | - |
| Other working capital | 5.39 Million | -1.21 Million | 6.87 Million | -2.76 Million | 6.55 Million | -56.15 Thousand |
| Cash at beginning of period | 108.24 Million | 23.99 Million | 14.54 Million | 3.5 Million | 7.11 Million | 10.2 Million |
| Cash at end of period | 62.39 Million | 108.24 Million | 23.99 Million | 14.54 Million | 3.55 Million | 7.11 Million |
| Capital Expenditure | - | - | - | - | -498.99 Thousand | - |
| Effect of forex changes on cash | -27 Thousand | 1.06 Million | 130 Thousand | -348 Thousand | 65.24 Thousand | 370.47 Thousand |
| Net cash flow / Change in cash | -45.85 Million | 84.24 Million | 9.44 Million | 11.04 Million | -3.56 Million | -3.08 Million |
| Free Cash Flow | -100.17 Million | -117.55 Million | -64.99 Million | -33.23 Million | -16.62 Million | -24.21 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -18.62 Million | -24.9 Million | -91.06 Million | -215.81 Million | -31.69 Million | -43.49 Million |
| Depreciation & Amortization | - | - | 75.33 Thousand | 75.33 Million | - | - |
| Deferred income taxes | - | - | -77.56 Thousand | -83.21 Million | - | - |
| Stock-based compensation | - | - | 2224.00 | 7.88 Million | 3468.00 | - |
| Change in working capital | -20.53 Million | 4.71 Million | -13.33 Million | 30.37 Million | 13.67 Million | 3.05 Million |
| Other non-cash items | 3.01 Million | 9 Million | 84 Million | 85.26 Million | 3.36 Million | 5.78 Million |
| Investing Cash Flow | - | - | - | 370 Thousand | 2000.00 | 132 Thousand |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | 370 Thousand | 2000.00 | 132 Thousand |
| Financing Cash Flow | 47.48 Million | -154 Thousand | 54.56 Million | 53.98 Million | -153 Thousand | -179 Thousand |
| Debt repayment | - | - | - | -729.00 | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -135.35 Thousand | - | - | - |
| Common Stock Issuance | - | - | - | 59.45 Million | - | - |
| Other Financing Activities | 47.48 Million | -154.00 | 189.91 Thousand | -5.47 Million | -153 Thousand | -179 Thousand |
| Accounts receivables | - | - | 19.87 Thousand | 19.87 Million | - | - |
| Accounts payables | - | - | - | 5.1 Million | - | - |
| Inventory | - | - | - | 1000.00 | - | - |
| Other working capital | -20.53 Million | 4716.00 | -13.35 Million | 5.39 Million | 13.67 Million | 3.05 Million |
| Cash at beginning of period | 51.55 Million | 62.39 Million | 28.87 Million | 108.24 Million | 44.42 Million | 78.21 Million |
| Cash at end of period | 62.79 Million | 51.55 Million | 62.39 Million | 62.39 Million | 28.87 Million | 44.42 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | -85 Thousand | 501 Thousand | -647 Thousand | -27 Thousand | -741 Thousand | 911 Thousand |
| Net cash flow / Change in cash | 11.24 Million | -10.84 Million | 33.51 Million | -45.85 Million | -15.54 Million | -33.79 Million |
| Free Cash Flow | -36.15 Million | -11.18 Million | -20.39 Million | -100.17 Million | -14.65 Million | -34.65 Million |
RAIL
ANNX
ALLR
AGNPF
WALL-B
SAI